In Takeda Pharmaceutical Company Limited v. Zydus Pharmaceuticals (USA) Inc., Eric Gaier was retained on behalf of Takeda in connection with antitrust counterclaims filed by Zydus Pharmaceuticals. Zydus alleged that Takeda filed “sham” patent litigation to delay Zydus’s launch of a generic formulation of Takeda’s Prevacid® SoluTab™ drug. Dr. Gaier testified on behalf of Takeda concerning market definition, market power, competitive effects, and damages in connection with Zydus’s antitrust counterclaims. The District Court granted Takeda’s motion for summary judgment on the antitrust counterclaims.
The team
Partner
Partner
